Henrik Jørn Ditzel (Henrik J Ditzel)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 49

Top Venues

Nature communications

International journal of molecular sciences

Cancers

Molecular cancer

University of Southern Denmark (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Southern Denmark

Denmark

PHD

Publications

Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Charlotte K Kindt, Carla L Alves, Sidse Ehmsen, Amalie Kragh, Thomas Reinert, Marianne Vogsen, Annette R Kodahl, Jeanette D Rønlev, Dilan Ardik, Anna L Sørensen, Kirstine Evald, Mia L Clemmensen, Johan Staaf, Henrik Jørn Ditzel
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer. International journal of cancer (2024)
Amanda Frydendahl, Mads Heilskov Rasmussen, Sarah Østrup Jensen, Tenna Vesterman Henriksen, Christina Demuth, Mathilde Diekema, Henrik Jørn Ditzel, Sara Witting Christensen Wen, Jakob Skou Pedersen, Lars Dyrskjøt, Claus Lindbjerg Andersen
Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNA. International journal of molecular sciences 25 (8) (2024)
Sofie Traynor, Mie K Jakobsen, Tina M Green, Hana Komic, Yaseelan Palarasah, Christina B Pedersen, Henrik Jørn Ditzel, Fredrik B Thoren, Per Guldberg, Morten Frier Gjerstorff
Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer. Journal for immunotherapy of cancer 12 (6) (2024)
Sofie Traynor, Mie K Jakobsen, Tina M Green, Hana Komic, Yaseelan Palarasah, Christina B Pedersen, Henrik Jørn Ditzel, Fredrik B Thoren, Per Guldberg, Morten Frier Gjerstorff
Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer. Journal for immunotherapy of cancer 12 (6) (2024)
Amanda Frydendahl, Mads Heilskov Rasmussen, Sarah Østrup Jensen, Tenna Vesterman Henriksen, Christina Demuth, Mathilde Diekema, Henrik Jørn Ditzel, Sara Witting Christensen Wen, Jakob Skou Pedersen, Lars Dyrskjøt, Claus Lindbjerg Andersen
Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNA. International journal of molecular sciences 25 (8) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Carla L Alves, Henrik Jørn Ditzel
Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer. International journal of molecular sciences 24 (5) (2023)
Carla L Alves, Henrik Jørn Ditzel
Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer. International journal of molecular sciences 24 (5) (2023)
Carla L Alves, Henrik Jørn Ditzel
Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer. International journal of molecular sciences 24 (5) (2023)
Leena Karimi, Carla L Alves, Mikkel G Terp, Martina Tuttolomondo, Neil Portman, Sidse Ehmsen, Lene E Johansen, Martin Bak, Elgene Lim, Henrik Jørn Ditzel
Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor. Cancer communications (London, England) (2023)
Odd L Gammelgaard, Mikkel G Terp, Christian Renn, Aran F Labrijn, Oliver Hamaker, Aaraby Yoheswaran Nielsen, Henriette Vever, Soren Wk Hansen, Morten Frier Gjerstorff, Christa Elisabeth Müller, Paul W H I Parren, Henrik Jørn Ditzel
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity. Journal for immunotherapy of cancer 10 (9) (2022)
Morten Frier Gjerstorff, Sofie Traynor, Odd L Gammelgaard, Simone Johansen, Christina B Pedersen, Henrik Jørn Ditzel, Mikkel G Terp
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer. Cancers 14 (24) (2022)
Malene Grubbe Hildebrandt, Kristian Kidholm, Jørgen Ejler Pedersen, Mohammad Naghavi-Behzad, Torben Knudsen, Aleksander Krag, Jesper Ryg, Oke Gerke, Annmarie Touborg Lassen, Torkell J Ellingsen, Henrik Jørn Ditzel, Vibeke Andersen, Annette Langhoff, Gert Nielsen, Tahir Masud, Anna-Marie Bloch Münster, Kirsten Ohm Kyvik, Kim Brixen
How to increase value and reduce waste in research: initial experiences of applying Lean thinking and visual management in research leadership. BMJ open 12 (6) (2022)
Shijun Ma, Yue Zhao, Wee Chyan Lee, Li-Teng Ong, Puay Leng Lee, Zemin Jiang, Gokce Oguz, Zhitong Niu, Min Liu, Jian Yuan Goh, Wenyu Wang, Matias A Bustos, Sidse Ehmsen, Adaikalavan Ramasamy, Dave S B Hoon, Henrik Jørn Ditzel, Ern Yu Tan, Qingfeng Chen, Qiang Yu
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy. Nature communications 13 (1) (2022)
Simone Johansen, Sofie Traynor, Malene Laage Ebstrup, Mikkel Green Terp, Christina Bøg Pedersen, Henrik Jørn Ditzel, Morten Frier Gjerstorff
ZBED1 Regulates Genes Important for Multiple Biological Processes of the Placenta. Genes 13 (1) (2022)
Malene Grubbe Hildebrandt, Kristian Kidholm, Jørgen Ejler Pedersen, Mohammad Naghavi-Behzad, Torben Knudsen, Aleksander Krag, Jesper Ryg, Oke Gerke, Annmarie Touborg Lassen, Torkell J Ellingsen, Henrik Jørn Ditzel, Vibeke Andersen, Annette Langhoff, Gert Nielsen, Tahir Masud, Anna-Marie Bloch Münster, Kirsten Ohm Kyvik, Kim Brixen
How to increase value and reduce waste in research: initial experiences of applying Lean thinking and visual management in research leadership. BMJ open 12 (6) (2022)
Abeer J Al-Qasem, Carla L Alves, Sidse Ehmsen, Martina Tuttolomondo, Mikkel G Terp, Lene E Johansen, Henriette Vever, Luna V A Hoeg, Daniel Elias, Martin Bak, Henrik Jørn Ditzel
Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer. NPJ precision oncology 6 (1) (2022)
Morten Frier Gjerstorff, Sofie Traynor, Odd L Gammelgaard, Simone Johansen, Christina B Pedersen, Henrik Jørn Ditzel, Mikkel G Terp
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer. Cancers 14 (24) (2022)
Malene Grubbe Hildebrandt, Kristian Kidholm, Jørgen Ejler Pedersen, Mohammad Naghavi-Behzad, Torben Knudsen, Aleksander Krag, Jesper Ryg, Oke Gerke, Annmarie Touborg Lassen, Torkell J Ellingsen, Henrik Jørn Ditzel, Vibeke Andersen, Annette Langhoff, Gert Nielsen, Tahir Masud, Anna-Marie Bloch Münster, Kirsten Ohm Kyvik, Kim Brixen
How to increase value and reduce waste in research: initial experiences of applying Lean thinking and visual management in research leadership. BMJ open 12 (6) (2022)
Natascha Skov, Carla L Alves, Sidse Ehmsen, Henrik Jørn Ditzel
Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer. International journal of molecular sciences 23 (17) (2022)
Li-Teng Ong, Wee Chyan Lee, Shijun Ma, Gokce Oguz, Zhitong Niu, Yi Bao, Mubaraka Yusuf, Puay Leng Lee, Jian Yuan Goh, Panpan Wang, Kylie Su Mei Yong, Qingfeng Chen, Wenyu Wang, Adaikalavan Ramasamy, Dave S B Hoon, Henrik Jørn Ditzel, Ern Yu Tan, Soo Chin Lee, Qiang Yu
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (31) (2022)
A Augusto Peluso, Stefan J Kempf, Thiago Verano-Braga, Lucas Rodrigues-Ribeiro, Lene Egedal Johansen, Mie Rytz Hansen, Gitte Kitlen, Andreas Houe Haugaard, Colin Sumners, Henrik Jørn Ditzel, Robson Augusto Souza Dos Santos, Michael Bader, Martin R Larsen, Ulrike Muscha Steckelings
Quantitative Phosphoproteomics of the Angiotensin AT 2 -Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and Apoptosis. Hypertension (Dallas, Tex. : 1979) 79 (11) (2022)
Behzad Mansoori, Mikkel Green Terp, Ali Mohammadi, Christina Bøg Pedersen, Henrik Jørn Ditzel, Behzad Baradaran, Morten Frier Gjerstorff
HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 13 (20) (2021)
Sanne Løkkegaard, Daniel Elias, Carla L Alves, Martin V Bennetzen, Anne-Vibeke Lænkholm, Martin Bak, Morten F Gjerstorff, Lene E Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S Lindström, Laura J Esserman, Anne E Lykkesfeldt, Jens S Andersen, Rikke Leth-Larsen, Henrik Jørn Ditzel
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit. NPJ breast cancer 7 (1) (2021)
Behzad Mansoori, Ali Mohammadi, Henrik Jørn Ditzel, Pascal H G Duijf, Vahid Khaze, Morten Frier Gjerstorff, Behzad Baradaran
HMGA2 as a Critical Regulator in Cancer Development. Genes 12 (2) (2021)
Mikkel G Terp, Odd L Gammelgaard, Henriette Vever, Morten F Gjerstorff, Henrik Jørn Ditzel
Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes. Molecular oncology 15 (12) (2021)
Carla L Alves, Sidse Ehmsen, Mikkel G Terp, Neil Portman, Martina Tuttolomondo, Odd L Gammelgaard, Monique F Hundebøl, Kamila Kaminska, Lene E Johansen, Martin Bak, Gabriella Honeth, Ana Bosch, Elgene Lim, Henrik Jørn Ditzel
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature communications 12 (1) (2021)
Abeer J Al-Qasem, Carla L Alves, Henrik Jørn Ditzel
Resistance Mechanisms to Combined CDK4/6 Inhibitors and Endocrine Therapy in ER+/HER2- Advanced Breast Cancer: Biomarkers and Potential Novel Treatment Strategies. Cancers 13 (21) (2021)
Mikkel G Terp, Kirstine Jacobsen, Miguel Ángel Molina-Vila, Niki Karachaliou, Hans C Beck, Jordi Bertran-Alamillo, Ana Giménez-Capitán, Andrés F Cardona, Rafael Rosell, Henrik Jørn Ditzel
Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells. NPJ precision oncology 5 (1) (2021)
Carla L Alves, Sidse Ehmsen, Mikkel G Terp, Neil Portman, Martina Tuttolomondo, Odd L Gammelgaard, Monique F Hundebøl, Kamila Kaminska, Lene E Johansen, Martin Bak, Gabriella Honeth, Ana Bosch, Elgene Lim, Henrik Jørn Ditzel
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature communications 12 (1) (2021)
Sona Hubackova, Eliska Davidova, Stepana Boukalova, Jaromira Kovarova, Martina Bajzikova, Ana R Coelho, Mikkel G Terp, Henrik Jørn Ditzel, Jakub Rohlena, Jiri Neuzil
Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors. Cell death & disease 11 (2) (2020)
Yi Bao, Gokce Oguz, Wee Chyan Lee, Puay Leng Lee, Kakaly Ghosh, Jiayao Li, Panpan Wang, Peter E Lobie, Sidse Ehmsen, Henrik Jørn Ditzel, Andrea Wong, Ern Yu Tan, Soo Chin Lee, Qiang Yu
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy. Nature communications 11 (1) (2020)
Behzad Mansoori, Pascal H G Duijf, Ali Mohammadi, Souzan Najafi, Elmira Roshani, Dariush Shanehbandi, Khalil Hajiasgharzadeh, Solmaz Shirjang, Henrik Jørn Ditzel, Tohid Kazemi, Ahad Mokhtarzadeh, Morten F Gjerstorff, Behzad Baradaran
Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness. Expert opinion on therapeutic targets (2020)
Sidse Ehmsen, Henrik Jørn Ditzel
Signaling pathways essential for triple-negative breast cancer stem-like cells. Stem cells (Dayton, Ohio) 39 (2) (2020)
Nadine H Brückmann, Sofie N Bennedsen, Pascal H G Duijf, Mikkel G Terp, Mads Thomassen, Martin Larsen, Christina B Pedersen, Torben Kruse, Nicolas Alcaraz, Henrik Jørn Ditzel, Morten Frier Gjerstorff
A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescence. Cell death & disease 10 (11) (2019)
Sambavy Nadaraja, Doris Schledermann, Jørn Herrstedt, Olga Østrup, Henrik Jørn Ditzel, null null
ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy. Acta oncologica (Stockholm, Sweden) 59 (1) (2019)
Sona Hubackova, Eliska Davidova, Katerina Rohlenova, Jan Stursa, Lukas Werner, Ladislav Andera, LanFeng Dong, Mikkel G Terp, Zdenek Hodny, Henrik Jørn Ditzel, Jakub Rohlena, Jiri Neuzil
Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2. Cell death and differentiation 26 (2) (2018)
Wenyu Wang, Gokce Oguz, Puay Leng Lee, Yi Bao, Panpan Wang, Mikkel Green Terp, Henrik Jørn Ditzel, Qiang Yu
KDM4B-regulated unfolded protein response as a therapeutic vulnerability in PTEN-deficient breast cancer. The Journal of experimental medicine 215 (11) (2018)
Martin H Pedersen, Brian L Hood, Sidse Ehmsen, Hans Christian Beck, Thomas P Conrads, Martin Bak, Henrik Jørn Ditzel, Rikke Leth-Larsen
CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients. International journal of cancer 144 (3) (2018)
Annette R Kodahl, Sidse Ehmsen, Niels Pallisgaard, Anne M B Jylling, Jeanette D Jensen, Anne-Vibeke Laenkholm, Ann S Knoop, Henrik Jørn Ditzel
Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer. Molecular oncology 12 (6) (2018)
Alexei F Kirkin, Karine N Dzhandzhugazyan, Per Guldberg, Johnny Jon Fang, Rikke Sick Andersen, Christina Dahl, Jann Mortensen, Tim Lundby, Aase Wagner, Ian Law, Helle Broholm, Line Madsen, Christer Lundell-Ek, Morten Frier Gjerstorff, Henrik Jørn Ditzel, Martin R Jensen, Walter Fischer
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells. Nature communications 9 (1) (2018)
Carla L Alves, Daniel Elias, Maria B Lyng, Martin Bak, Henrik Jørn Ditzel
SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer. Breast cancer research : BCR 20 (1) (2018)
Anne G Christensen, Sidse Ehmsen, Mikkel G Terp, Richa Batra, Nicolas Alcaraz, Jan Baumbach, Julie B Noer, José Moreira, Rikke Leth-Larsen, Martin R Larsen, Henrik Jørn Ditzel
Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening. Stem cells (Dayton, Ohio) 35 (8) (2017)
Richa Batra, Nicolas Alcaraz, Kevin Gitzhofer, Josch Pauling, Henrik Jørn Ditzel, Marc Hellmuth, Jan Baumbach, Markus List
On the performance of de novo pathway enrichment. NPJ systems biology and applications 3 (2017)
Jian Yuan Goh, Min Feng, Wenyu Wang, Gokce Oguz, Siti Maryam J M Yatim, Puay Leng Lee, Yi Bao, Tse Hui Lim, Panpan Wang, Wai Leong Tam, Annette R Kodahl, Maria B Lyng, Suman Sarma, Selena Y Lin, Alexander Lezhava, Yoon Sim Yap, Alvin S T Lim, Dave S B Hoon, Henrik Jørn Ditzel, Soo Chin Lee, Ern Yu Tan, Qiang Yu
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence. Nature medicine 23 (11) (2017)
Kirstine Jacobsen, Jordi Bertran-Alamillo, Miguel Angel Molina, Cristina Teixidó, Niki Karachaliou, Martin Haar Pedersen, Josep Castellví, Mónica Garzón, Carles Codony-Servat, Jordi Codony-Servat, Ana Giménez-Capitán, Ana Drozdowskyj, Santiago Viteri, Martin R Larsen, Ulrik Lassen, Enriqueta Felip, Trever G Bivona, Henrik Jørn Ditzel, Rafael Rosell
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer. Nature communications 8 (1) (2017)

Henrik Jørn Ditzel.css-eqlu8i{font-size:small;padding-left:4px;} (Henrik J Ditzel)

Publication Activity (10 Years)

Top Topics

Top Venues

Henrik Jørn Ditzel (Henrik J Ditzel)